Celltrion today announced that the European Commission (EC) has granted marketing authorization for Avtozma® (CT-P47), a biosimilar referencing RoActemra® (tocilizumab). Avtozma® has been approved for ...

A new robotic procedure designed to provide relief for men with an enlarged prostate is now available in the Midlands, offering another option for treatment for men in the region. Benign prostatic ...

Simbec-Orion and Avance Clinical are thrilled to announce the signing of a Memorandum of Understanding (MOU), marking a significant milestone in their strategic partnership. This formal agreement ...

Almirall as European leader in Medical Dermatology: we delivered impactful products to more patients and the medical community. Our double-digit sales growth and increased profitability demonstrate ...

Sanofi and Teva Pharmaceuticals, a US affiliate of Teva Pharmaceutical Industries Ltd., today presented new, detailed results from the RELIEVE UCCD phase 2b study of duvakitug, a human IgG1-λ2 ...

According to recent studies, between 400,000 and 600,000 people suffer hospital infections every year. A significant proportion of these infections could be avoided by targeted preventive measures.

GSK plc (LSE/NYSE: GSK) today announced that it has completed the acquisition of IDRx, Inc. (IDRx), a Boston-based, ...

The global Cell and Gene Therapy Market is valued at $20.5 billion in 2024 and is projected to reach a value of $128.8 ...

The Global Prefilled Syringes Market was valued at $5.43 billion in 2022 and is projected to reach $10.59 billion by 2030, ...

Market OverviewThe Global Smart Insulin Pens Market was valued USD 102.86 Million in 2022 and is anticipated to reach a value ...

The global Heart Failure Drugs Market is valued at $8.6 billion in 2024 and is projected to reach a value of $21.4 billion by 2035. This growth represents a Compound Annual Growth Rate (CAGR) of 12.1% ...

Market OverviewThe Global Orthopedic Implants Market was valued USD 43.85 Billion in 2022 and is anticipated to reach a value ...